HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Rie Yanagisawa Selected Research

1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)

1/2013Organic chemicals in diesel exhaust particles enhance picryl chloride-induced atopic dermatitis in NC/Nga mice.
2/2009Effects of diesel exhaust particles on antigen-presenting cells and antigen-specific Th immunity in mice.
1/2009Effects of pulmonary exposure to diesel exhaust particles on extrathoracic CD4 polarization in asthmatic mice.
11/2008Impact of diesel exhaust particles on th2 response in the lung in asthmatic mice.
8/2007Effects of naphthoquinone on airway responsiveness in the presence or absence of antigen in mice.
3/2007Components of diesel exhaust particles diversely enhance a variety of respiratory diseases related to infection or allergy: extracted organic chemicals and the residual particles after extraction differently affect respiratory diseases.
1/2007Effects of diesel exhaust particles on cytokine production by splenocytes stimulated with lipopolysaccharide.
1/2007Effects of components derived from diesel exhaust particles on lung physiology related to antigen.
1/2007Pulmonary exposure to diesel exhaust particles enhances fatty change of the liver in obese diabetic mice.
12/2006Effects of organic chemicals derived from ambient particulate matter on lung inflammation related to lipopolysaccharide.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Rie Yanagisawa Research Topics

Disease

43Inflammation
06/2014 - 01/2002
21Pneumonia (Pneumonitis)
12/2012 - 04/2003
16Asthma (Bronchial Asthma)
06/2014 - 01/2002
9Acute Lung Injury
11/2008 - 12/2002
8Atopic Dermatitis (Atopic Eczema)
08/2014 - 08/2006
6Lung Injury
04/2011 - 04/2002
5Shock
07/2009 - 03/2005
5Pancreatitis
07/2009 - 03/2005
5Disseminated Intravascular Coagulation
07/2009 - 03/2005
4Body Weight (Weight, Body)
03/2014 - 04/2004
4Arthritis (Polyarthritis)
01/2007 - 08/2003
3Obesity
06/2014 - 04/2007
3Hemorrhage
01/2013 - 06/2004
3Hypersensitivity (Allergy)
04/2010 - 11/2005
3Infection
03/2007 - 10/2004
3Lung Diseases (Lung Disease)
11/2006 - 04/2003
2Eosinophilia
10/2010 - 08/2010
2Diabetes Mellitus
04/2007 - 01/2007
2Pulmonary Edema
09/2006 - 12/2002
2Rheumatoid Arthritis
07/2004 - 07/2003
1Type 2 Diabetes Mellitus (MODY)
08/2014
1Skin Diseases
02/2014
1Colitis
05/2013
1Peritonitis
06/2012
1Emphysema
03/2010
1Disease Progression
03/2010
1Pulmonary Emphysema
03/2010
1Metaplasia
01/2009
1Rhinitis
09/2007
1Hyperplasia
08/2007
1Vascular Diseases (Vascular Disease)
11/2006

Drug/Important Bio-Agent (IBA)

21Vehicle Emissions (Emissions, Vehicle)IBA
06/2014 - 05/2002
21CytokinesIBA
06/2014 - 01/2002
211-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
01/2013 - 04/2002
11ChemokinesIBA
06/2014 - 05/2002
10AntigensIBA
02/2009 - 08/2003
8Particulate MatterIBA
06/2014 - 09/2006
7Immunoglobulins (Immunoglobulin)IBA
02/2014 - 07/2002
7Immunoglobulin G (IgG)IBA
04/2010 - 01/2002
6Interleukin-6 (Interleukin 6)IBA
12/2012 - 06/2004
6Silicon Dioxide (Sand)FDA LinkGeneric
01/2012 - 11/2005
6urinastatin (MR 20)IBA
07/2009 - 03/2005
5phthalic acid (phthalate)IBA
02/2014 - 08/2006
5OvalbuminIBA
06/2012 - 07/2002
5Serine Proteases (Serine Protease)IBA
07/2009 - 03/2005
4MetallothioneinIBA
05/2013 - 01/2005
4Organic ChemicalsIBA
01/2013 - 11/2004
4Interleukin-5 (Interleukin 5)IBA
03/2007 - 01/2002
4InterleukinsIBA
01/2007 - 06/2004
4rosmarinic acidIBA
07/2006 - 04/2003
3Diethylhexyl Phthalate (DEHP)IBA
02/2014 - 08/2006
3Immunoglobulin E (IgE)IBA
01/2013 - 01/2002
3SootIBA
04/2011 - 09/2006
3Carbon Nanotubes (Carbon Nanotube)IBA
04/2010 - 12/2008
3Interleukin-1beta (Interleukin 1 beta)IBA
03/2010 - 01/2004
3CarbonIBA
12/2008 - 09/2006
3Vitamin EFDA LinkGeneric
10/2004 - 12/2002
2PlasticizersIBA
08/2014 - 05/2009
2diisononyl phthalateIBA
02/2014 - 04/2010
2PeroxiredoxinsIBA
12/2012 - 10/2009
2OzoneIBA
12/2012 - 12/2008
2Pancreatic Elastase (Elastase)IBA
04/2011 - 03/2010
2Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
11/2008 - 03/2005
2Leukocyte Elastase (Neutrophil Elastase)IBA
11/2008 - 03/2005
2Interleukin-13IBA
08/2007 - 08/2005
2RolipramIBA
01/2007 - 07/2004
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
04/2005 - 05/2002
1butylphenIBA
08/2014
14-nonylphenolIBA
08/2014
14-tert-octylphenolIBA
08/2014
1MercuryIBA
08/2014
1Surface-Active Agents (Surfactants)IBA
08/2014
1Glucose (Dextrose)FDA LinkGeneric
03/2014
1Biological Markers (Surrogate Marker)IBA
10/2013
1Picryl Chloride (Trinitrochlorobenzene)IBA
01/2013
1pinacolyl methylphosphonochloridate (PICL)IBA
01/2013
1thymic stromal lymphopoietinIBA
04/2010
1ruberythric acid (AlP)IBA
03/2010
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2010
1Methacholine Chloride (Methacholine)FDA Link
03/2010
1Alkaline PhosphataseIBA
03/2010
1Interleukin-2 (IL2)IBA
10/2009
1EstersIBA
05/2009
1titanium dioxide (Titania)FDA Link
03/2009
1LatexIBA
01/2009
1Interleukin-17 (Interleukin 27)IBA
01/2009
1Dacarbazine (DIC)FDA LinkGeneric
11/2008
1Aluminum Oxide (Sapphire)IBA
05/2008
1Butylated Hydroxytoluene (BHT)IBA
09/2007
1KaolinIBA
09/2007
1FructosamineIBA
04/2007
1Blood Glucose (Blood Sugar)IBA
04/2007
1Proanthocyanidins (Procyanidins)IBA
04/2007
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2007
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
01/2007
1E-SelectinIBA
11/2006
1Fibrinogen (Factor I)FDA Link
11/2006

Therapy/Procedure

1Oral Administration
02/2014
1Intraperitoneal Injections
02/2014
1Aftercare (After-Treatment)
12/2008